SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Arkadios Wealth Advisors

Arkadios Wealth Advisors lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 39,598 shares of the exchange traded fund’s stock after selling 1,593 shares during the quarter. Arkadios Wealth Advisors’ holdings in SPDR S&P Biotech ETF were worth $3,912,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Affinity Asset Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 105.4% during the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after acquiring an additional 737,550 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of SPDR S&P Biotech ETF by 30.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares in the last quarter. Mirae Asset Securities USA Inc. purchased a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth about $55,626,000. Jane Street Group LLC lifted its holdings in SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after buying an additional 391,333 shares during the last quarter. Finally, Baymount Management LP acquired a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth about $34,160,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI traded down $0.10 during midday trading on Friday, hitting $97.15. 6,256,079 shares of the company’s stock were exchanged, compared to its average volume of 9,406,488. The firm’s fifty day simple moving average is $99.14 and its 200-day simple moving average is $94.60. The company has a market cap of $7.40 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.